FDA-Compliant Opioid Prescribing CME

CO*RE CME

Learn to weigh opioids' risks and benefits

The free CO*RE CME program on safe opioid prescribing is offered by osteopathic affiliate groups across the country.

Opioid pain relievers are prescribed every day to millions of Americans who experience chronic pain. Unfortunately, since 2012 prescription opioid drug abuse, misuse, and addiction have reached epidemic proportions.² In 2018, approximately 67,000 deaths occurred due to drug overdose across the United States, and 70% of these deaths involving opioids.¹

To take action against the opioid crisis, the AOA joined forces with the CO*RE Collaborative to provide healthcare professionals with CME on pain management and safer opioid prescribing. The CO*RE curriculum is in alignment with the FDA’s mission and follows the FDA Blueprint (September, 2018).

After completing a CO*RE CME course, learners will be able to:

Describe the pathophysiology of pain as it relates to the concepts of pain management
Accurately assess patients in pain
Develop a safe and effective pain treatment plan
Identify evidence-based non-opioid options for the treatment of pain
Identify the risks and benefits of opioid therapy
Manage ongoing opioid therapy
Recognize behaviors that may be associated with an opioid use disorder

Upcoming CO*RE Courses

New York State Osteopathic Medical Society – Sept. 13, 2020
American College of Family Physicians – California – Oct. 10, 2020
American College of Osteopathic Internists – Oct. 25, 2020
Georgia Osteopathic Medical Association – Nov. 7, 2020
Michigan Osteopathic Association – Nov. 7, 2020

Past CO*RE Courses

Arkansas Osteopathic Medical Association – Aug. 6, 2020

References

Hedegaard H, Miniño AM, Warner M. Drug Overdose Deaths in the United States. 1999-2018. NCHS Data Brief, no 356. Hyattsville, MD: National Center for Health Statistics. 2020
White House. Epidemic: Responding to America’s Prescription Drug Abuse Crisis. (2013)